Intranasal Nanovaccine Confers Homo- and Hetero-Subtypic Influenza Protection
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Intranasal Nanovaccine Confers Homo- and Hetero-Subtypic Influenza Protection
Authors
Keywords
-
Journal
Small
Volume 14, Issue 13, Pages 1703207
Publisher
Wiley
Online
2018-02-12
DOI
10.1002/smll.201703207
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Basic Physicochemical Properties of Polyethylene Glycol Coated Gold Nanoparticles that Determine Their Interaction with Cells
- (2016) Pablo del Pino et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Viral-mimicking protein nanoparticle vaccine for eliciting anti-tumor responses
- (2016) Nicholas M. Molino et al. BIOMATERIALS
- Engineered Human Ferritin Nanoparticles for Direct Delivery of Tumor Antigens to Lymph Node and Cancer Immunotherapy
- (2016) Bo-Ram Lee et al. Scientific Reports
- Protective Efficacy of the Conserved NP, PB1, and M1 Proteins as Immunogens in DNA- and Vaccinia Virus-Based Universal Influenza A Virus Vaccines in Mice
- (2015) Wenling Wang et al. Clinical and Vaccine Immunology
- Advancements in the development of subunit influenza vaccines
- (2015) Naru Zhang et al. MICROBES AND INFECTION
- Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection
- (2015) Hadi M Yassine et al. NATURE MEDICINE
- Intranasal and oral vaccination with protein-based antigens: advantages, challenges and formulation strategies
- (2015) Shujing Wang et al. Protein & Cell
- Development of Cross-Protective Influenza A Vaccines Based on Cellular Responses
- (2015) Peter Christiaan Soema et al. Frontiers in Immunology
- Protection against Multiple Influenza A Virus Strains Induced by Candidate Recombinant Vaccine Based on Heterologous M2e Peptides Linked to Flagellin
- (2015) Liudmila A. Stepanova et al. PLoS One
- Protection against Influenza A Virus Challenge with M2e-Displaying Filamentous Escherichia coli Phages
- (2015) Lei Deng et al. PLoS One
- Cross Protection against Influenza A Virus by Yeast-Expressed Heterologous Tandem Repeat M2 Extracellular Proteins
- (2015) Yu-Na Lee et al. PLoS One
- Supplementation of Influenza Split Vaccines with Conserved M2 Ectodomains Overcomes Strain Specificity and Provides Long-term Cross Protection
- (2014) Min-Chul Kim et al. MOLECULAR THERAPY
- The immune system likes nanotechnology
- (2014) Istvan Toth et al. Nanomedicine
- Influenza M2 virus-like particles confer a broader range of cross protection to the strain-specific pre-existing immunity
- (2014) Min-Chul Kim et al. VACCINE
- AS04-adjuvanted virus-like particles containing multiple M2 extracellular domains of influenza virus confer improved protection
- (2014) Yu-Na Lee et al. VACCINE
- Nanoclusters self-assembled from conformation-stabilized influenza M2e as broadly cross-protective influenza vaccines
- (2013) Li Wang et al. Nanomedicine-Nanotechnology Biology and Medicine
- Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies
- (2013) Masaru Kanekiyo et al. NATURE
- Nanoparticle vaccines
- (2013) Liang Zhao et al. VACCINE
- An M2e-based synthetic peptide vaccine for influenza A virus confers heterosubtypic protection from lethal virus challenge
- (2013) Ji-Hong Ma et al. Virology Journal
- Virus-like particles as universal influenza vaccines
- (2012) Sang-Moo Kang et al. Expert Review of Vaccines
- Mucosal IgA responses in influenza virus infections; thoughts for vaccine design
- (2012) Elly van Riet et al. VACCINE
- Universal Vaccine Based on Ectodomain of Matrix Protein 2 of Influenza A: Fc Receptors and Alveolar Macrophages Mediate Protection
- (2010) K. El Bakkouri et al. JOURNAL OF IMMUNOLOGY
- Intranasal DNA Vaccination Induces Potent Mucosal and Systemic Immune Responses and Cross-protective Immunity Against Influenza Viruses
- (2010) Lea Torrieri-Dramard et al. MOLECULAR THERAPY
- Ambiguities in applying traditionalLimulusAmebocyte Lysate tests to quantify endotoxin in nanoparticle formulations
- (2010) Marina A Dobrovolskaia et al. Nanomedicine
- Influenza A viruses: why focusing on M2e-based universal vaccines
- (2010) Seyyed Mahmoud Ebrahimi et al. VIRUS GENES
- Structural basis for the function and inhibition of an influenza virus proton channel
- (2008) Amanda L. Stouffer et al. NATURE
- CTA1-M2e-DD: A novel mucosal adjuvant targeted influenza vaccine
- (2008) Dubravka Grdic Eliasson et al. VACCINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search